Background: The co-administration of letrozole during controlled ovarian stimulation (COS) with gonadotropins is used to limit the potentially harmful effects of a supra-physiological rise in estrogen levels on hormone-sensitive cancers. However, the efficacy and safety of adding letrozole to COS re...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!